Comparison of Immune Response Following Surgical Management of Renal Tumors

This study has been terminated.
Sponsor:
Information provided by (Responsible Party):
Kenneth Ogan, MD, Emory University
ClinicalTrials.gov Identifier:
NCT00289146
First received: February 7, 2006
Last updated: September 23, 2013
Last verified: September 2013
  Purpose

Examine the effects of renal surgery on the immune system.


Condition
Kidney Cancer

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Comparison of Immune Response Following Surgical Management of Renal Tumors

Resource links provided by NLM:


Further study details as provided by Emory University:

Biospecimen Retention:   Samples Without DNA

Blood samples


Estimated Enrollment: 50
Study Start Date: November 2005
Study Completion Date: August 2006
Primary Completion Date: August 2006 (Final data collection date for primary outcome measure)
Detailed Description:

Prospective study examining the effects of different surgical procedures on immune function. This may have bearing on overall cancer specific recurrence and survival.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Patients undergoing open or laparoscopic surgeries for the treatment of kidney tumors.

Criteria

Inclusion Criteria:

  • Kidney tumor patients scheduled for open or laparoscopic surgery

Exclusion Criteria:

-

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00289146

Locations
United States, Georgia
Emory University
Atlanta, Georgia, United States, 30322
Sponsors and Collaborators
Emory University
Investigators
Principal Investigator: Kenneth Ogan, MD Emory University
  More Information

No publications provided

Responsible Party: Kenneth Ogan, MD, Associate Professor, Emory University
ClinicalTrials.gov Identifier: NCT00289146     History of Changes
Other Study ID Numbers: 0021-2005
Study First Received: February 7, 2006
Last Updated: September 23, 2013
Health Authority: United States: Food and Drug Administration

Keywords provided by Emory University:
kidney cancer, immunology

Additional relevant MeSH terms:
Carcinoma, Renal Cell
Kidney Neoplasms
Adenocarcinoma
Carcinoma
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type
Neoplasms
Urologic Neoplasms
Urogenital Neoplasms
Neoplasms by Site
Kidney Diseases
Urologic Diseases

ClinicalTrials.gov processed this record on September 29, 2014